Vincent Aurentz
Board Member
Inhibikase Therapeutics, Inc. (IKT)Equibles does not estimate personal net worth.
Get an email with a short summary when Inhibikase Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IKT alertsAbout Vincent Aurentz
Vincent Aurentz is recorded as Board Member at Inhibikase Therapeutics, Inc. (IKT). The newest filing on record that lists Vincent Aurentz as Board Member at Inhibikase Therapeutics, Inc. (IKT) is dated April 30, 2026. Inhibikase Therapeutics, Inc. reported in an 8-K filed February 24, 2025 that Vincent Aurentz was appointed Class I director, effective February 21, 2025. Inhibikase Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibikase Therapeutics, Inc. includes Mark Iwicki (CEO and Board Member), Amit Munshi (Chairman and Board Member), Roberto Bellini (Chairman and Board Member) and 4 others.
“The Board also expanded its size from seven to eight directors and appointed Vincent Aurentz to serve as a Class I director of the Board.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Inhibikase Therapeutics, Inc.
- Mark Iwicki CEO, Board Member
- Amit Munshi Chairman, Board Member
- Roberto Bellini Chairman, Board Member
- David McIntyre CFO
- Arvind Kush Board Member
- David Canner Board Member
- Scott Wasserman Board Member